A detailed history of Jpmorgan Chase & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Jpmorgan Chase & CO holds 29,854,783 shares of JNJ stock, worth $4.62 Billion. This represents 0.43% of its overall portfolio holdings.

Number of Shares
29,854,783
Previous 29,752,159 0.34%
Holding current value
$4.62 Billion
Previous $4.66 Billion 1.27%
% of portfolio
0.43%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $15.9 Million - $16.7 Million
102,624 Added 0.34%
29,854,783 $4.72 Billion
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $241 Million - $263 Million
-1,656,048 Reduced 5.27%
29,752,159 $4.66 Billion
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $58.2 Million - $65.2 Million
-373,884 Reduced 1.18%
31,408,207 $4.89 Billion
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $935 Million - $1.01 Billion
6,058,575 Added 23.55%
31,782,091 $5.26 Billion
Q1 2023

May 18, 2023

BUY
$151.05 - $180.26 $186 Million - $222 Million
1,230,500 Added 5.02%
25,723,516 $3.99 Billion
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $1.08 Billion - $1.29 Billion
-7,169,461 Reduced 22.64%
24,493,016 $3.8 Billion
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $245 Million - $275 Million
1,530,390 Added 5.08%
31,662,477 $5.59 Billion
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $45.2 Million - $50.3 Million
-280,341 Reduced 0.92%
30,132,087 $4.92 Billion
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $758 Million - $838 Million
4,504,550 Added 17.39%
30,412,428 $5.4 Billion
Q1 2022

May 11, 2022

SELL
$158.14 - $179.59 $439 Million - $498 Million
-2,773,327 Reduced 9.67%
25,907,878 $4.59 Billion
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $284 Million - $316 Million
1,823,976 Added 6.79%
28,681,205 $4.91 Billion
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $4.34 Billion - $4.82 Billion
26,857,229 New
26,857,229 $4.34 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.